142 results
8-K
xtviubo3edk6h po0
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
PRE 14C
bhd2blx xg
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.1
wrqk37yp2zlwqs
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
mswd77cat9
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
1mo0o yeg75
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
6x1l fmv1as6vhn
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm